4//SEC Filing
GILEAD SCIENCES INC 4
Accession 0001127602-17-010300
$GILDCIK 0000882095operating
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:03 PM ET
Size
7.0 KB
Accession
0001127602-17-010300
Insider Transaction Report
Form 4
MOORE NICHOLAS G
Director
Transactions
- Exercise/Conversion
Phantom Stock
2017-03-01−173→ 25,640 totalExercise: $0.00→ Common Stock (173 underlying) - Exercise/Conversion
Common Stock
2017-03-01+173→ 12,055 total
Footnotes (3)
- [F1]Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.
- [F2]An aggregate of 173.167681 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.167681 was paid out in cash in connection with the conversion into shares of common stock.
- [F3]The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.
Documents
Issuer
GILEAD SCIENCES INC
CIK 0000882095
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000882095
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:03 PM ET
- Size
- 7.0 KB